Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Abatacept may help some people with alopecia areata regrow hair.

Alefacept does not effectively treat severe alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

JAK inhibitors are effective treatments for alopecia areata.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Apremilast did not work for treating severe alopecia areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.